Novo Nordisk Battles Unapproved Drug Copies in South Africa Court
Novo Nordisk, the Danish pharmaceutical giant, is making a legal bid to stop iDexis from selling unauthorized copies…
Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say
By Bhanvi Satija and Chris Prentice LONDON/NEW YORK, May 21 (Reuters) – Lower prices for weight-loss pills from…
Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say
By Bhanvi Satija and Chris Prentice LONDON/NEW YORK, May 21 (Reuters) – Lower prices for weight-loss pills from…
Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say
By Bhanvi Satija and Chris Prentice LONDON/NEW YORK, May 21 (Reuters) – Lower prices for weight-loss pills from…
Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say
By Bhanvi Satija and Chris Prentice LONDON/NEW YORK, May 21 (Reuters) – Lower prices for weight-loss pills from…
Novo Nordisk & Hims & Hers Deal: Wegovy, Ozempic Sales on Platform – News and Statistics
Mar 9, 2026 According to a report from Yahoo Finance, Novo Nordisk has agreed to dismiss a patent…
Novo Nordisk, Hims & Hers settle GLP-1 drug dispute
Listen to this article The basics: Novo Nordisk and Hims & Hers have ended a legal feud with…
Hims & Hers pulls copycat Wegovy pill amid legal action
Listen to this article The basics: Hims & Hers pauses compounded semaglutide pill rollout Novo Nordisk sues over…
HIMS offers low-cost oral GLP-1 weight-loss pill in us challenging novo
Listen to this article Summary: Hims launched a $49 compounded oral GLP-1 weight-loss pill in the US, significantly…
Novo Nordisk threatens legal action over Hims Wegovy copy
Listen to this article The basics: Novo Nordisk warns Hims & Hers over $49 compounded, copycat version of…